MAPK3 and breast carcinoma: Hyaluronan, CD44 and another hyaluronan receptor, receptor for hyaluronan mediated motility (RHAMM) have been shown to form signaling complexes with extracellular regulated kinase 1/2 (ERK1/2), leading to increased motility of breast cancer cells [42].